@article{8aaa0d6ffe9f4a789613da35e504a7fb,
title = "A Phase I Study Of Myeloablative Radioimmunotherapy Using Iodine-131 Anti-CD45 Antibody Followed By Autologous Stem Cell Transplantation For High-Risk B-Cell and T-Cell Non-Hodgkin Lymphoma and Hodgkin Lymphoma",
author = "Press, \{Oliver W.\} and Pagel, \{John M.\} and Rajendran, \{Joseph G.\} and Gooley, \{Theodore A.\} and Fisher, \{Darrell R.\} and Lundberg, \{Sally J.\} and Hedin, \{Lacey M.\} and Shields, \{Andrew T.\} and Green, \{Damian J.\} and Miyaoka, \{Robert S.\} and Appelbaum, \{Frederick R.\} and Gopal, \{Ajay K.\}",
note = "Background High-dose therapy and autologous stem cell transplant (ASCT) remains the standard of care for many high-risk/relapsed B-cell non-Hodgkin lymphomas (B-NHL), T-cell NHL (T-NHL) and classical Hodgkin lymphoma (HL), yet most will not achieve sustained remissions.",
year = "2013",
month = nov,
day = "15",
language = "American English",
volume = "122",
journal = "Blood",
}